Retrieved January 14, 2015 V&A # 31/2015 of the EU Procedure determines no: UK/H/1641/001/II/010 type II variation: c. I z) are authorized the following variation: Introduction of the first version of the Risk Management Plan in relation to medicine: CYTARABINE ACCORD and at authorised pack sizes the placing in Italy following the mutual recognition procedure.
MAh: Accord Healthcare Italy S.r.l.
Inventory disposal lots already products can be kept on the market until the expiration date printed on the label of the medicinal product in accordance with art. 1 subparagraph 5 of determines AIFA n. 371 of 14/04/2014 published in the Official Gazette No. 101 of May 3, 2014. Date of determination: from the day following that of its publication, to decompress, in Gazzetta Ufficiale della Repubblica italiana.